DalsnaFinance

Travere Therapeutics stock hits 52-week high at 48.7 USD

Markets Investing.com By Investing.com 09 Jun 2026 13:55 1 min read
Travere Therapeutics stock hits 52-week high at 48.7 USD

Travere Therapeutics stock hits 52-week high at 48.7 USD

Travere Therapeutics stock hits 52-week high at 48.7 USD

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.